As of 2025-12-25, the Relative Valuation of Constellation Pharmaceuticals Inc (CNST) is (61.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.99 USD, the upside of Constellation Pharmaceuticals Inc based on Relative Valuation is -279.6%.
The range of the Relative Valuation is (57.02) - (64.02) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 21.8x | 20.4x |
| Forward P/E multiples | 19.4x - 22.9x | 21.2x |
| Fair Price | (57.02) - (64.02) | (61.05) |
| Upside | -267.8% - -288.4% | -279.6% |
| Date | P/E |